Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
Open Access
- 5 December 2022
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 22 (1) , 1-14
Abstract
Background: It is well-established that biochemical recurrence is detrimental to prostate cancer (PCa). In the present study, we explored the mechanisms underlying PCa progression.Methods: Five cohorts from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus databases were used to perform gene set variation analysis (GSVA) between nonrecurrent and recurrent PCa patients. We obtained the intersection of pathway enrichment results and extracted the corresponding gene list. LASSO Cox regression analysis was used to identify recurrence-free survival (RFS)-related significant genes and establish an RFS prediction gene signature and nomogram. MTT and colony formation assays were conducted to validate our findings.Results: The E2F signaling pathway was activated in recurrent PCa patients compared to nonrecurrent patients. We established an E2F-related gene signature for RFS prediction based on the four identified E2F-related genes (CDKN2C, CDKN3, RACGAP1, and RRM2) using LASSO Cox regression in the Memorial Sloan Kettering Cancer Center (MSKCC) cohort. The risk score of each patient in MSKCC was calculated based on the expression levels of CDKN2C, CDKN3, RACGAP1, and RRM2. PCa patients with low-risk scores exhibited higher RFS than those with high-risk scores. Receiver operating characteristic (ROC) curve analysis validated the good performance and prognostic accuracy of the E2F-related gene signature, which was validated in the TCGA-prostate adenocarcinoma (TCGA-PRAD) cohort. Compared to patients with low Gleason scores and early T stages, PCa patients with high Gleason scores and advanced T stages had high-risk scores. Moreover, the E2F-related gene signature-based nomogram yielded good performance in RFS prediction. Functional experiments further confirmed these results.Conclusions: The E2F signaling pathway is associated with biochemical recurrence in PCa. Our established E2F-related gene signature and nomogram yielded good accuracy in predicting the biochemical recurrence in PCa.Keywords
Funding Information
- National Natural Science Foundation of China (81700662, 81630019, 8227081)
- Natural Science Research Project Funding of Higher Education Institutions of Anhui Province (KJ2019A0279)
This publication has 46 references indexed in Scilit:
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyThe Lancet Oncology, 2011
- Identification of early molecular markers for breast cancerMolecular Cancer, 2011
- The RB-E2F1 Pathway Regulates AutophagyCancer Research, 2010
- Emerging roles of E2Fs in cancer: an exit from cell cycle controlNature Reviews Cancer, 2009
- Cell‐context specific role of the E2F/Rb pathway in development and diseaseGlia, 2009
- Broad Overexpression of Ribonucleotide Reductase Genes in Mice Specifically Induces Lung NeoplasmsCancer Research, 2008
- Involvement of E2F transcription factor family in cancerEuropean Journal of Cancer, 2005
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Molecular Features of the Transition from Prostatic Intraepithelial Neoplasia (PIN) to Prostate CancerCancer Research, 2004